Search the Newsreel

TriCo Bancshares Q2 FY26 net income rises 24.1% to $34.17 million; net interest margin widens 23 bps to 4.11%

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) Who Suffered Losses to Contact the Firm Before September 28, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor's stock price fell significantly after the FDA released …

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

Hagens Berman has filed a securities fraud class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) following allegations that the company made misleading statements about its Deramiocel clinical trial data and regulatory pathway. Investors who suffered substantial losses between December 17, 2025, and July …

Stephens Upgrades TriCo Bancshares (NASDAQ:TCBK) to "Overweight"

Stephens has upgraded TriCo Bancshares (NASDAQ:TCBK) from "equal weight" to "overweight." Despite this, the broader analyst consensus remains "Hold" with a target price of $56.60. TriCo Bancshares recently surpassed earnings estimates, reporting $1.06 EPS against an expected $1.03, and revenue of $111.88 million, exceeding …

Results: Marico Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Capricorn Metals (ASX:CMM) Could Be 73% Undervalued Following Its Growth Update

Is TriCo Bancshares (TCBK) Fully Valued Following Strong Q2 Earnings?

TriCo Bancshares (TCBK) reported strong Q2 2026 earnings, showing increased net interest income, net income, and EPS, which has driven a significant share price increase over the last year. While its P/E ratio of 13.6x appears overvalued compared to its estimated fair P/E and …

CREDIT AGRICOLE SA: 2026 CAPITAL INCREASE RESERVED FOR EMPLOYEES

CREDIT AGRICOLE SA Press release Montrouge, 6 August 2026 2026 CAPITAL INCREASE RESERVED FOR EMPLOYEES Crédit Agricole S.A.'s capital increase reserved for more than 190,000 employees and retired former employees¹ of the Crédit Agricole Group (ACR 2026), for which the subscription period ran from …

Americold Realty Trust Q2 2026 Earnings Call Transcript

Americold Realty Trust (NYSE: COLD) reported strong Q2 2026 results, exceeding expectations for AFFO per share at $0.35, driven by improved operating trends and market share gains. The company raised its full-year AFFO guidance to $1.26-$1.32 per share, despite a $0.05 per-share dilution from …

Americold raises 2026 AFFO guidance to $1.26-$1.32 per share while targeting leverage of 6x or less

Earnings Call Insights: Americold Realty Trust (COLD) Q2 2026 MANAGEMENT VIEW * Robert Chambers (President, CEO & Director) said, “our team delivered another strong quarter,” and highlighted “ongoing signs of stabilization across the industry,” alongside “strong execution, market share gains and continued progress against …

Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between …

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor failed to disclose that it changed the statistical …

Americold Realty Trust (COLD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Americold Realty Trust Inc. (COLD) reported $662.89 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 1.9%. EPS of $0.35 for the same period compares to $0.01 a year ago. The reported revenue represents a surprise of +5.34% over …

Americold Realty Trust Inc. (COLD) Q2 FFO and Revenues Surpass Estimates

Americold Realty Trust Inc. (COLD) reported Q2 FFO of $0.35 per share and revenues of $662.89 million, both surpassing Zacks Consensus Estimates. Despite outperforming FFO expectations for three of the last four quarters, the stock has underperformed the S&P 500 year-to-date and currently holds …

Americold misses Q2 EPS, raises full-year guidance By Investing.com

Americold Realty Trust reported a Q2 net loss of $1.19 per share, missing analyst estimates, despite exceeding revenue expectations with $662.9 million. The loss was primarily due to a significant impairment charge related to winding down operations at two facilities. Despite this, the company …

Earnings Flash (COLD) Americold Realty Trust, Inc. Reports Q2 Revenue $662.9M, vs. FactSet Est of $613.5M

Americold Realty Trust, Inc. (COLD) reported strong Q2 revenue of $662.9 million, significantly exceeding the FactSet estimate of $613.5 million. The company also announced an expected adjusted FFO per share range of $1.26 to $1.32 for 2026, surpassing the FactSet estimate of $1.24. Additionally, …

Americold Realty Trust, Inc. Reports Unaudited Consolidated Impairment of Long-Lived Assets for the Second Quarter Ended June 30, 2026

Americold Realty Trust, Inc. reported a significant unaudited consolidated impairment of long-lived assets totaling $309,572,000 for the second quarter ended June 30, 2026. This figure represents a substantial increase compared to $5,226,000 reported in the same period a year ago. The report was published …

Americold Realty Trust: Americold Announces Second Quarter 2026 Results

Americold Realty Trust announced strong second-quarter 2026 results, with Adjusted FFO of $0.35 per diluted share, exceeding expectations and showing increased total revenues year-over-year. The company raised its full-year Adjusted FFO guidance to $1.26 to $1.32 per share, attributing the positive outlook to continued …

A $309.6M impairment drove Americold's $342.8M Q2 loss

Americold Realty Trust (NYSE:COLD) Issues FY 2026 Earnings Guidance

Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) on behalf of investors who purchased shares between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made false or misleading statements, which led to …

Ahold Delhaize winds down plans for 2 automated frozen warehouses

Ahold Delhaize USA and Americold Realty Trust are ending their agreement for two automated frozen warehouses, with one facility in Pennsylvania winding down operations by year-end and another in Connecticut halting plans immediately. This decision will result in a significant non-cash impairment charge for …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Capricor Therapeutics, Inc. (CAPR) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating Capricor Therapeutics, Inc. (CAPR) following a significant stock price drop after the FDA released critical briefing documents concerning Capricor's cell therapy for Duchenne muscular dystrophy. The FDA documents questioned the scientific justification of Capricor's data measurement methods …

Is Crédit Agricole (ENXTPA:ACA) Stock A Bargain Or Fully Priced?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Crédit Agricole stock has delivered a strong 133.8% return over the past five years, …

ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Rosen Law Firm has announced a class action lawsuit against Capricor Therapeutics, Inc. for alleged materially false and/or misleading statements regarding changes to their Deramiocel clinical trial analysis plan without FDA agreement. Investors who purchased Capricor securities between December 17, 2025, and July 26, …

Marico's 'Boringly Consistent' Growth For Another Quarter Bags Jefferies Target Price Hike

Buzzing Stocks: Bharti Hexacom, Marico slip despite strong Q1 earnings; Deepak Nitrite gains 3% on profit...

Marico's Stock Slides Over 3% Even As Q1 Net Profit, Revenue Beat Estimates

Masi Agricola, i risultati finanziari del 1° semestre 2026

Imricor Medical Systems (ASX:IMR) Slides as Healthcare Traders Lock In Profits

Buy, Sell Or Hold: Kaynes Technology, Ather Energy, Marico, Groww, Azad India Mobility — Ask Profit

Americold Realty Trust, Inc. (COLD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Americold Realty Trust, Inc. (COLD) after the company announced an expected non-cash impairment charge of $305 million to $320 million. This charge follows the termination and wind-down agreement for two automated distribution centers, causing …

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made undisclosed changes to its statistical analysis …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Americold Realty Trust, Inc. - COLD

Pomerantz LLP is investigating Americold Realty Trust, Inc. (NYSE: COLD) for potential securities fraud after the company announced an expected non-cash impairment charge of $305 million to $320 million. This charge stems from the termination of an agreement with ADUSA Distribution, leading to the …

CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) …